Point72 Asset Management
PHAT icon

Point72 Asset Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Point72 Asset Management’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
+1,022,193
New +$11.7M 0.01% 1220
2024
Q4 		– Sell
-439,816
Closed -$7.95M – 2364
2024
Q3 		$7.95M Buy
+439,816
New +$6.15M 0.02% 729
2023
Q2 		– Sell
-11,505
Closed -$82.1K – 2644
2023
Q1 		$82.1K Buy
+11,505
New +$101K ﹤0.01% 1674

Other funds holding PHAT

Frazier Life Sciences Management
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Point72 Asset Management's PHAT Position: Q2 2026 in Review

Point72 Asset Management opened a new position in Phathom Pharmaceuticals (PHAT) in Q2 2026: 1,022,193 shares worth $11.1M. The stake represents 0.01% of the portfolio and ranks #1220 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in PHAT as recently as Q3 2024.

Point72 Asset Management first reported a position in PHAT in Q1 2023 and has held it in 3 quarters since. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Point72 Asset Management held 1,022,193 shares of Phathom Pharmaceuticals worth $11.1M as of Q2 2026.
  • Phathom Pharmaceuticals was a new Point72 Asset Management position in Q2 2026.
  • Phathom Pharmaceuticals made up 0.01% of Point72 Asset Management's portfolio in Q2 2026, its #1220 holding.
  • Point72 Asset Management first reported a position in Phathom Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.